Mike the one sentence that you should have put in your article was: The release of data was authorized and coordinated with the FDA beforehand!!!
Another tidbit of information was that the interim was at 20% separation while the final only needs to be at 22% separation. I believe that this near miss in the interim was the reason the DMC and the FDA and DNDN all reviewed the data together to determine if the trial should be stopped due to its significant efficacy. They decided to wait until the final data that is due for release in April.
Another piece of information missing is that in the 2 previous phase 3 trials they achieved a combined curve separation of 33% at final and this trial is tracking the previous trials.
Perhaps you also forgot to mention that this is the first biological treatment for cancer on track to be approved by the FDA and that this will be a whole new way of treating cancer. You also forgot to mention that company has at least 12 other cancers treatments are going to use the same cassette technology. With the breast cancer treatment has gone through phase 1 trials and has show similar results to the prostate treatment now nearing approval.
The hedge funds have screwed up by betting against this company and are using their media outlets to scare the retail investor so they can get out of their short positions without too much financial pain.
Dendreon: The FDA's Commissioner Doth Protest Too Much! [View article]
Hey Been There and LIED HERE
I think that you must provide your credentials that prove that your are better equipped to judge the efficacy of Provenge. If 13 members of 17 voted for efficacy and the 3 who voted against were severely conflicted I would say that the vote was virtually unanimous. But since you are the GOD of immunology and look down upon those poor mortal experts in the field please perform a miracle so we can all believe. Say how about stopping the war in IRAQ and make everyone put down their hatred.
Can't do that? Then how about listing you credentials, or better yet the Hedge fund that you are connected with.
Did Dendreon Play with Fire? [View article]
Another tidbit of information was that the interim was at 20% separation while the final only needs to be at 22% separation. I believe that this near miss in the interim was the reason the DMC and the FDA and DNDN all reviewed the data together to determine if the trial should be stopped due to its significant efficacy. They decided to wait until the final data that is due for release in April.
Another piece of information missing is that in the 2 previous phase 3 trials they achieved a combined curve separation of 33% at final and this trial is tracking the previous trials.
Perhaps you also forgot to mention that this is the first biological treatment for cancer on track to be approved by the FDA and that this will be a whole new way of treating cancer. You also forgot to mention that company has at least 12 other cancers treatments are going to use the same cassette technology. With the breast cancer treatment has gone through phase 1 trials and has show similar results to the prostate treatment now nearing approval.
The hedge funds have screwed up by betting against this company and are using their media outlets to scare the retail investor so they can get out of their short positions without too much financial pain.
Dendreon: The FDA's Commissioner Doth Protest Too Much! [View article]
I think that you must provide your credentials that prove that your are better equipped to judge the efficacy of Provenge. If 13 members of 17 voted for efficacy and the 3 who voted against were severely conflicted I would say that the vote was virtually unanimous. But since you are the GOD of immunology and look down upon those poor mortal experts in the field please perform a miracle so we can all believe. Say how about stopping the war in IRAQ and make everyone put down their hatred.
Can't do that? Then how about listing you credentials, or better yet the Hedge fund that you are connected with.